scispace - formally typeset
J

Jean-Philippe Brosseau

Researcher at University of Texas Southwestern Medical Center

Publications -  29
Citations -  1169

Jean-Philippe Brosseau is an academic researcher from University of Texas Southwestern Medical Center. The author has contributed to research in topics: RNA splicing & Alternative splicing. The author has an hindex of 12, co-authored 27 publications receiving 824 citations. Previous affiliations of Jean-Philippe Brosseau include Centre Hospitalier Universitaire de Sherbrooke & Université de Sherbrooke.

Papers
More filters
Journal ArticleDOI

Identification of alternative splicing markers for breast cancer.

TL;DR: A new approach for the identification of breast cancer markers that does not measure gene expression but instead uses the ratio of alternatively spliced mRNAs as its indicator is presented, providing a simple alternative for the classification of normal and cancerous breast tumor tissues and underscore the putative role of alternative splicing in the biology of cancer.
Journal ArticleDOI

RBFOX2 is an important regulator of mesenchymal tissue-specific splicing in both normal and cancer tissues.

TL;DR: By knocking down 78 potential splicing factors in five cell lines, this work provides an extensive view of the complex regulatory landscape associated with the epithelial and mesenchymal states, thus revealing that RBFOX2 is an important driver of mesenchyal tissue-specific splicing.
Journal ArticleDOI

Alternative splicing of SYK regulates mitosis and cell survival

TL;DR: The data suggest that splicing of selected genes is specifically modified during tumor development to allow the expression of isoforms that promote cancer cell survival, including the pro-survival isoform that is associated with cancer tissues in vivo.
Journal ArticleDOI

Contributions of inflammation and tumor microenvironment to neurofibroma tumorigenesis

TL;DR: In this article, the role of inflammation in neurofibromagenesis was investigated in a genetically engineered Scf mice to decipher the contributions of tumor-derived SCF and mast cells to neuro-fibroma development and showed that mast cell infiltration is dependent on SCF from tumor Schwann cells.